In:
Cancer Medicine, Wiley, Vol. 5, No. 12 ( 2016-12), p. 3500-3511
Kurzfassung:
Steroid receptor coactivator‐3 ( SRC ‐3), a transcriptional coactivator for nuclear receptors and other transcription factors, plays an important role in the genesis and progression of several cancers. However, studies investigated the role of SRC ‐3 in esophageal squamous cell carcinomas ( ESCC s) are limited, and the role of SRC ‐3 in tumor progression remains unclear. We examined the expression of SRC ‐3 in 8 ESCC cell lines and 302 human ESCC tissues by qPCR , Western blot, and immunohistochemistry. In addition, ESCC cell lines were subjected to proliferation and invasion assays, tumorigenicity assay, flow cytometry assay, qPCR , Western blot, and Chromatin Immunoprecipitation assay to investigate the role of SRC ‐3 in cancer progression. SRC ‐3 was overexpressed in 48% of cases and correlated with poor overall ( P = 0.0076) and progression‐free ( P = 0.0069) survival of surgically resected ESCC patient. Cox regression analysis revealed that SRC ‐3 is an independent prognostic marker. Furthermore, we found that activation of insulin‐like growth factor ( IGF )/ AKT ) was involved in the SRC ‐3 on the cell growth and invasiveness in two ESCC cell lines, Eca109 and EC 18 cells. SRC ‐3 overexpression is clinically and functionally relevant to the progression of human ESCC , and might be a useful molecular target for ESCC prognosis and treatment.
Materialart:
Online-Ressource
ISSN:
2045-7634
,
2045-7634
DOI:
10.1002/cam4.2016.5.issue-12
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2016
ZDB Id:
2659751-2
